Stephanie Gasking

Search
Speakers

Stephanie Gasking is an oncology Medical Science Liaison with more than 20 years of experience in the pharmaceutical industry. She contributes to research and real-world evidence generation, and has co-authored peer-reviewed oncology publications. Stephanie is passionate about connecting research, clinical practice and scientific exchange to help improve care and outcomes for people with cancer.

Abstracts this author is presenting:

Health-related quality of life (HRQoL) with tepotinib in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) with brain, liver, adrenal or bone metastases in the Phase II VISION trial — Afternoon Tea, Exhibition & Poster Session 1
AUSTRALI-AVE: design of a retrospective noninterventional study evaluating real-world patient characteristics and treatment patterns with avelumab in locally advanced or metastatic urothelial cancer (la/mUC) and metastatic Merkel cell carcinoma (mMCC) in Australia — Afternoon Tea, Exhibition & Poster Session 2

Stephanie Gasking Clinical Oncology Society of Australia Annual Scientific Meeting 2024

Stephanie Gasking

Abstracts this author is presenting: